Albiglutide - Superior Diabetes Treatment Option
ProcurenetShort description
Albiglutide: Superior Diabetes Treatment
A potent treatment for type 2 diabetes mellitus, Albiglutide is a recombinant DNA-produced polypeptide analogue of human GLP-1. Key features include:
- Boosts pancreatic β-cells function: Enhances insulin secretion.
- Reduces blood sugar: Lowers blood sugar concentration and Hb A1c levels.
- Varied packaging options: Available in 1g, 5g, 10g, 20g, 50g, and 100g sizes.
Emulating natural GLP-1 structure with a composite sequence of amino acids, it efficiently regulates blood sugar levels. An ideal research-grade product for proficient diabetes management by health professionals and patients. Recommended dosage: 30mg weekly via subcutaneous injection.
-
Procurenet Team Tshim Sha Tsui
Hong Kong
3 years
Description
Albiglutide - A Revolutionary Diabetes Treatment
Albiglutide steps into the forefront of diabetes treatment as a recombinant DNA-produced, polypeptide analogue of human glucagon-like peptide-1 (GLP-1). Its superior design and functionality make it an indispensable ally in managing type 2 diabetes mellitus and an influential factor in the world of diabetes research.
Powerful Features and Benefits
- Highly specialized treatment for type 2 diabetes mellitus.
- Aids in the function of pancreatic beta cells, playing an essential part in controlling blood sugar levels.
- Triggers efficient intracellular signal transductions, thereby enhancing insulin secretion.
- Leads to decreased blood sugar concentration and reduction in glycosylated hemoglobin (Hb A1c) levels.
- Availability in varying quantities (1g, 5g, 10g, 20g, 50g, 100g) ensures convenience for diverse research needs.
- Fulfills international safety standards and clinically validated for optimal results.
- Research-grade product, opening avenues for broad usage in multiple applications.
Albiglutide's unique selling point lies in its sophisticated design that allows it to facilitate signal transduction, regulated by cell membrane-coupled G protein, after binding to the GLP-1 receptor found on pancreatic beta cells. This binding results in restored and improved function of the beta cells, leading to an increase in insulin secretion. It stands as a testament to its effectiveness in controlling blood sugar levels and reducing glycosylated hemoglobin (Hb A1c).
Given its research-grade, Albiglutide can be employed in various applications, thereby making it a versatile solution for diabetes management. Available in a range of quantities, it offers flexibility and convenience to meet different research requirements. Its adherence to international safety standards further promotes its reliability and trustworthiness.
Embrace the change in diabetes management with Albiglutide. It is more than a product; it's your partner in creating a future free from the complications of diabetes.
